AI-generated · cited to primary sources · not investment advice
Venus Pipes (543528) Aug 2025 Filing Analysis
Does management do what it says?
Q1 FY26 EBITDA margin stood at 16.2%, which is within the guided range of 16-18%. (3 met across 3 tracked commitments)
“And anything on the margin front, because you have given 16% to 18% range at this point of time. Kunal Bubna: We have maintained that & We maintain the same.”
The company is pursuing new product and plant-based approvals in Middle East and Southeast Asia to increase its Total Addressable Market. (+1 more commitment)
“Faster approvals expected, given our strong relations and proven track record of delivering quality products”
The company is installing piercing lines to ensure full backward integration.
“We will also be the installing piercing lines to ensure we remain fully backward integrated.”
See the full cited Management analysis of Venus Pipes
What could break the thesis?
Margins remain under pressure; EBITDA margin dropped to 16.2% in Q1FY26 from 20.0% in Q1FY25, a significant 370 basis point decline. (1 intensifying)
“EBITDA Margins (%) 16.2% 20.0% -370 bps”
See the full cited Risk analysis of Venus Pipes
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.